Anthem Biosciences Limited

NSE: ANTHEM

Healthcare Healthcare

₹808.5

-1.66%EOD · 19 Oct

Anthem Biosciences Limited is a listed Healthcare company on NSE/BSE. Detailed profile data is being compiled — check BSE filings for the latest disclosures.

Market Cap

₹45,561 Cr

52W Range

₹978 / ₹579

Volume

361K

54.7% delivery

1Y Return

+1.0%

P/E Ratio

81.0

P/B Ratio

15.2

ROE

21.7%

Debt / Equity

1.77

Peers in Healthcare

Top 8 by market cap

Company	LTP	Market Cap	P/E	P/B	ROE %	Div Yld %
Anthem Biosciences Limited(this stock)	₹808.5	₹45,561 Cr	81.0	15.2	21.7%	0.24%
Divi's Laboratories LimitedDIVISLAB	₹9,087	₹2.41 L Cr	83.0	14.5	16.2%	0.33%
Torrent Pharmaceuticals LimitedTORNTPHARM	₹4,558.7	₹1.73 L Cr	72.8	18.4	17.0%	0.83%
Laurus Labs LimitedLAURUSLABS	₹2,069	₹1.12 L Cr	101.8	21.0	17.7%	0.12%
Zydus Lifesciences LimitedZYDUSLIFE	₹1,113.9	₹1.11 L Cr	25.0	4.2	18.3%	0.09%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP	₹7,700	₹1.11 L Cr	54.3	12.0	21.5%	0.25%
Aurobindo Pharma LimitedAUROPHARMA	₹1,621.4	₹93,292 Cr	26.1	2.6	9.9%	0.00%
Mankind Pharma LimitedMANKIND	₹2,253.2	₹93,067 Cr	46.0	5.8	12.4%	0.00%
Max Healthcare Institute LimitedMAXHEALTH	₹830	₹80,785 Cr	56.7	7.7	14.3%	0.23%

Quality Score

Durability · Valuation · Momentum — objective math, not advice

57/100

Composite score: 40% quality, 30% valuation, 30% momentum

QualityStrong · 75

ValuationPoor · 10

MomentumStrong · 80

High ROE (21.7%)

In confirmed uptrend (Stage 2)

Very expensive valuation (P/E 81x)

Technical Indicators

Full analysis · objective math, not advice

Returns

-1.7%

-8.5%

-12.8%

+2.1%

+12.1%

+1.0%

Weinstein Stage

Stage 2 — Advancing (uptrend)

RSI (14)

39 Neutral

Trend Template

6/7strong

RS vs Nifty (3M)

+6.6pp

Moving Averages (price vs MA)

20-DMA

₹866

below

50-DMA

₹891

below

150-DMA

₹796

above

200-DMA

₹760

above

From 52W High

-17.3%

From 52W Low

+39.6%

Support (20D)

₹803

Resistance (20D)

₹947

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.